Spectrophotometric and spectrofluorimetric methods for analysis of acyclovir and acebutolol hydrochloride

Simple and sensitive spectrophotometric and spectrofluorimetric methods are described for analysis of acyclovir and acebutolol hydrochloride. The proposed methods are based on oxidation of the selected drugs with cerium(IV) ion in acidic medium with subsequent measurement of either the decrease in absorbance at 320nm or the fluorescence intensity of the produced cerous(III) ion at 361-363nm (excitation at 250nm). Beer's law obeyed from 2 to 8, 0.25 to 2.5microgcm-1 acyclovir, 1 to 7 and 0.25 to 2.5microgml-1 acebutolol hydrochloride, using the spectrophotometric and spectrofluorimetric method, respectively. The proposed method were successfully applied for determination of the selected drugs in their pharmaceutical preparations with good recoveries.     

Spectrophotometric and spectrofluorimetric methods for analysis of acyclovir and acebutolol hydrochloride

Simple and sensitive spectrophotometric and spectrofluorimetric methods are described for analysis of acebutolol hydrochloride. The proposed methods are based on oxidation of the selected drug with cerium(IV) ion in acidic medium with subsequent measurement of either the decrease in absorbance at 320 nm or the fluorescence intensity of the produced cerous(III) ion at 363 nm (excitation at 250 nm). Beer's law obeyed from 1.0-7.0 microg ml(-1) and 0.25-2.5 microg ml(-1) acebutolol hydrochloride, using the spectrophotometric and spectrofluorimetric method, respectively. The proposed methods were successfully applied for determination of the selected drug in its pharmaceutical preparation with good recoveries.     

Spectrophotometric and spectrofluorimetric methods for analysis of tramadol, acebutolol and dothiepin in pharmaceutical preparations

Sensitive spectrophotometric and spectrofluorimetric methods are described for the determination of tramadol, acebutolol and dothiepin (dosulepin) hydrochlorides. The two methods are based on the condensation of the cited drugs with the mixed anhydrides of malonic and acetic acids at 60 degrees C for 25-40 min. The coloured condensation products are suitable for the spectrophotometric and spectrofluorimetric determination at 329-333 and 431-434 nm (excitation at 389 nm), respectively. For the spectrophotometric method, Beer's law was obeyed from 0.5 to 2.5 microg ml(-1) for tramadol, dothiepin and 5-25 microg ml(-1) for acebutolol. Using the spectrofluorimetric method linearity ranged from 0.25 to 1.25 microg ml(-1) for tramadol, dothiepin and 1-5 microg ml(-1) for acebutolol. Mean percentage recoveries for the spectrophotometric method were 99.68+/-1.00, 99.95+/-1.11 and 99.72+/-1.01 for tramadol, acebutolol and dothiepin, respectively and for the spectrofluorimetric method, recoveries were 99.5+/-0.844, 100.32+/-0.969 and 99.82+/-1.15 for the three drugs, respectively. The optimum experimental parameters for the reaction has been studied. The validity of the described procedures was assessed. Statistical analysis of the results has been carried out revealing high accuracy and good precision. The proposed methods were successfully applied for the determination of the selected drugs in their pharmaceutical preparations with good recoveries. The procedures were accurate, simple and suitable for quality control application.     

Spectrophotometric and spectrofluorimetric methods for the determination of pregabalin in bulk and pharmaceutical preparation

Two new, sensitive and selective spectrofluorimetric and spectrophotometric methods have been developed for the determination of the gamma-amino-n-butyric acid derivative pregabalin (PGB) in bulk drug and capsule. Pregabalin, as a primary amine compound, reacts with 7-chloro-4-nitrobenzofurazon (NBD-Cl) which is a highly sensitive fluorogenic and chromogenic reagent used in many investigations. According to this fact, spectrophotometric and spectrofluorimetric methods for the determination of pregabalin in capsules were developed for the first time. The relation between the absorbance at 460 nm and the concentration is rectilinear over the range 0.5-7.0 microg mL(-1). The reaction product was also measured spectrofluorimetrically at 558 nm after excitation at 460 nm. The fluorescence intensity was directly proportional to the concentration over the range 40-400 ng mL(-1). The method was applied successfully to the determination of this drug in pharmaceutical dosage form. The mean recovery for the commercial capsules was 99.93% and 99.96% for spectrophotometric and spectrofluorimetric study, respectively. The suggested procedures could be used for the determination of PGB in pure and capsules being sensitive, simple and selective.     

Spectrophotometric, spectrofluorimetric, and densitometric methods for the determination of indapamide

Three sensitive spectrophotometric, spectrofluorimetric, and densitometric methods are described for the determination of indapamide. The first and second methods are based on the oxidative coupling reaction of indapamide with 3-methyl-2-benzothiazolinone hydrazone HCl (MBTH) in the presence of cerium(IV) ammonium sulfate in an acidic medium. The absorbance of the reaction product is measured at the lambdamax, 601 nm. With the same reaction, indapamide is determined by its quenching effect on the fluorescence of excess cerous ions at the emission lambdamax, 350 nm, and the excitation at lambdamax, 300 nm. The reaction conditions were optimized, and Beer's law was obeyed for indapamide at 1.2-9.6 microg/mL with mean recoveries of 99.92 +/- 0.83 and 99.97 +/- 1.11%, respectively. The third method, a stability-indicating densitometric assay, was developed for the determination of indapamide, using toluene-ethyl acetate-glacial acetic acid (69 + 30 + 1, v/v/v) as the developing system and scanning at the lambdamax, 242 nm, in the presence of the degradation product and related substance; for the indapamide concentration range of 0.6-6 microg/spot, the mean recovery was 99.73 +/- 0.71%. The proposed methods were successfully applied to the determination of indapamide in bulk powder and commercial tablets, and the results of the analysis agreed statistically with those obtained with the official method. Furthermore, the methods were validated according to the guidelines of the U.S. Pharmacopeia and also assessed by applying the standard additions technique.     

Spectrophotometric determination of paracetamol in drug formulations by oxidation with potassium dichromate

A rapid spectrophotometric method for determination of paracetamol is described, based on oxidation with dichromate for 15 min in 6M sulphuric acid at 80 degrees , and measurement (at 580 nm) of the chromium(III) formed. The method is applied to the determination of paracetamol in drugs prescribed for colds, coughs and flu. Of the common pharmaceuticals associated with paracetamol, only ascorbic acid and acetylsalicylic acid interfere. The results have been statistically compared with those obtained by the official (BP) and cerium(IV) methods.     

Fluorimetric trace determination of cerium(III) with sodium triphosphate

Sodium triphosphate acts as a specific reagent for enhancing the fluorescence intensity of cerium(III). The purpose of this study was to investigate the spectrofluorimetric determination of trace amounts of Ce(III) in sodium triphosphate solution. The excitation and emission wavelengths are 303.5 nm and 353 nm respectively. Optimum sodium triphosphate concentration is found to be 0.074 g l(-1) at room temperature. The fluorescence varies linearly with the concentration of cerium(III) in the range 0.001-45 mug ml(-1). The detection limit is 9.4 x 10(-4)mug ml(-1). The relative standard deviations for 30 mug ml(-1) and 0.05 mug ml(-1) Ce(III) in 0.074 g l(-1) sodium triphosphate solution are 1.1% and 0.72% respectively. Quenching effects of other lanthanides and some inorganic anions are described. This method is a direct and rapid analytical method for the determination of Ce(III) in rare earth mixtures and cerium concentrates.     

Spectrofluorimetric Determination of the Hypertensive Drug Captopril Based on Its Oxidation with Cerium(IV)

A highly sensitive and specific spectrofluorimetric method for the analysis of captopril (CAP) in the pure form and in the tablet dosage forms has been described. The method was based on the oxidation of captopril by cerium(IV) in the presence of sulphuric acid and subsequent monitoring the fluorescence of the induced Ce(III) ion produced at λ_ex = 256 nm and λ_em = 354 nm. All variables affecting the reaction conditions such as cerium(IV) concentration, type and concentration of acid medium, reaction time, diluting solvents, temperature and heating time were carefully studied and optimized. Under the experimental conditions used, an excellent linear relationship was obtained between fluorescence intensity and the concentration of CAP. A linear range of determination was verified for captopril concentrations between 0.1–1.3 μg mL^?1 and the correlation coefficient of determination was 0.9997. Quantitation and detection limits were calculated. The precision of the method was satisfactory; the values of relative standard deviations did not exceed 1.14%. No interference could be observed from the excipients and additives are commonly presented in dosage forms. The proposed method was applied successfully for the assay of the studied drug in pure form and in pharmaceutical dosage forms. Recovery experiments revealed recovery of 99.82–100.21%. The results of the analysis show a good agreement with those obtained by official method stated in the United State Pharmacopoeia.     

Spectrophotometric determination of some drugs for osteoporosis

Three simple, accurate and sensitive spectrophotometric methods are developed for the determination of some new drugs for the treatment of osteoporosis: risedronate sodium (I), alendronate sodium (II) and etidronate disodium (III). The first method is based on the measurement of difference in absorbance (Delta A) of risedronate sodium in 0.01 mol l(-1) hydrochloric and 0.1 mol l(-1) sodium hydroxide at 262 nm. Beer's law is obeyed over a concentration range of 15-150 microg ml(-1) with mean recovery 99.75+/-1.22 and molar absorptivity (epsilon) 1.891 x 10(3). The second method is based on the reaction of the primary amino group of (II) with ninhydrin reagent in methanolic medium in the presence of 0.05 mol l(-1) sodium bicarbonate. The colored product is measured at 568 nm, and the linearity range is found to be 3.75-45 microg ml(-1) with mean recovery 99.77+/-0.73 and epsilon 9.425 x 10(3). The third method is based on oxidation of the three mentioned drugs with ceric (IV) sulphate in 0.5 mol l(-1) sulphuric acid at room temperature and subsequent measurement of the excess unreacted cerium (IV) sulphate at 320 nm. The method obeyed Beer's law over a concentration range of 2-24 microg ml(-1) for the three drugs with mean recovery 99.79+/-1.16, 99.73+/-1.38 and 99.86+/-1.13 and epsilon 14.427 x 10(3), 13.813 x 10(3) and 14.000 x 10(3) for drugs I, II, III respectively. The proposed methods were successfully applied for the determination of the studied drugs in bulk powder and in pharmaceutical formulations. The results were found to agree statistically with those obtained the reported methods. Furthermore, the methods were validated according to USP regulations and also assessed by applying the standard addition technique.     

钙黄绿素荧光法测定痕量钇(Ⅲ)

研究了钙黄绿素荧光法测定Y(Ⅲ)。在pH 8.0的H3BO3-Na2B4O7缓冲溶液和表面活性剂Tween 80的存在下,痕量Y(Ⅲ)能与钙黄绿素反应形成配合物,使体系的荧光强度显著增加,体系的激发和发射波长分别为492和512nm,Y(Ⅲ)的质量浓度在0～2.0μg/mL范围内与△F成良好的线性关系,其线性回归方程为:△F=3.2648+2.384ρ(μg/mL),相关系数r=0.9961,检出限为0.023μg/mL。方法用于乙酸铈中痕量钇(Ⅲ)的测定,测定结果与ICP-AES法相符,加标回收率在96.3%～103.0%之间。     

Flow injection method for the assay of the anti-arrhythmic procainamide HCl in drug formulations utilizing statistical optimization techniques

A flow injection spectrophotometric method for the determination of procainamide HCl was explored. The method was based on the oxidation of procainamide HCl with cerium(IV) in sulphuric acid media and subsequent monitoring of the absorbance of the oxidized form of the drug at 480 nm. A sample rate of 250 samples per hour was attained. The procedure was optimized by the Factorial Design at two upper and lower levels of the five parameters sample loop size, flow rate, coil length, sulphuric acid and cerium(IV) concentrations. The latter three indicated high interactions and revealed significance to peak height value therefore optimized by the Super Modified Simplex programme. The optimized FI system with a linear calibration range of 100-600 ppm was found to be adequate and suitable for determination of procainamide HCl in proprietary drugs. A high degree of accuracy of the results was demonstrated by a statistical comparison with those obtained by the British Pharmacopoeia method of the same batch of drugs.     

Spectrophotometric determination of H(2)-receptor antagonists via their oxidation with cerium(IV)

A simple, accurate and sensitive spectrophotometric method has been developed and validated for determination of H(2)-receptor antagonists: cimetidine, famotidine, nizatidine and ranitidine hydrochloride. The method was based on the oxidation of these drugs with cerium(IV) in presence of perchloric acid and subsequent measurement of the excess Ce(IV) by its reaction with p-dimethylaminobenzaldehyde to give a red colored product (lambda(max) at 464nm). The decrease in the absorption intensity of the colored product (DeltaA), due to the presence of the drug was correlated with its concentration in the sample solution. Different variables affecting the reaction were carefully studied and optimized. Under the optimum conditions, linear relationships with good correlation coefficients (0.9990-0.9994) were found between DeltaA values and the concentrations of the drugs in a concentration range of 1-20microgml(-1). The assay limits of detection and quantitation were 0.18-0.60 and 0.54-1.53microgml(-1), respectively. The method was validated, in terms of accuracy, precision, ruggedness and robustness; the results were satisfactory. The proposed method was successfully applied to the determination of the investigated drugs in pure and pharmaceutical dosage forms (recovery was 98.3-102.6+/-0.57-1.90%) without interference from the common excipients. The results obtained by the proposed method were comparable with those obtained by the official methods.     

Spectrofluorimetric determination of acrivastine in spiked human urine and pharmaceuticals

A spectrofluorimetric method to determine acrivastine is proposed and applied to its determination in human urine and pharmaceuticals. The fluorimetric method allows the determination of 58-2000 ng ml(-1) of acrivastine in aqueous solutions containing acetic acid-sodium acetate buffer (pH 6.5) with lambda(exc)=230 nm and lambda(em)=380 nm.     

Stability-indicating methods for determination of tiapride in pure form, pharmaceutical preparation, and human plasma

Four different stability-indicating procedures are described for determination of tiapride in pure form, dosage form, and human plasma. Second derivative (D2), first derivative of ratio spectra (1DD), spectrofluorimetric, and high-performance column liquid chromatographic (LC) methods are proposed for determination of tiapride in presence of its acid-induced degradation products, namely 2-methoxy-5-(methylsulfonyl) benzoic acid and 2-diethylaminoethylamine. These approaches were successfully applied to quantify tiapride using the information included in the absorption, excitation, and emission spectra of the appropriate solutions. In the D2 method, Beer's law was obeyed in the concentration range of 1.5-9 microg/mL with a mean recovery of 99.94 +/- 1.38% at 253.4 nm using absolute ethanol as a solvent. In 1DD, which is based on the simultaneous use of the first derivative of ratio spectra and measurement at 245 nm in absolute ethanolic solution, Beer's law was obeyed over a concentration range of 1.5-9 microg/mL with mean recovery 99.64 +/- 1.08%. The spectrofluorimetric method is based on the determination of tiapride native fluorescence at 339 nm emission wavelength and 230 nm excitation wavelength using water-methanol (8 + 2, v/v). The calibration curve was linear over the range of 0.2-3 microg/mL with mean recovery of 99.66 +/- 1.46%. This method was also applied for determination of tiapride in human plasma. A reversed-phase LC method performed at ambient temperature was validated for determination of tiapride using methanol-deionized water-triethylamine (107 + 93 + 0.16, v/v/v) as the mobile phase. Sulpiride was used as an internal standard at a flow rate of 1 mL/min with ultraviolet detection at 214 nm. A linear relation was obtained over a concentration range of 2-30 microg/mL with mean recovery of 99.66 +/- 0.9%. Results were statistically analyzed and compared with those obtained by applying the reference method. They proved both accuracy and precision.     

Spectrofluorimetric determination of two β-agonist drugs in bulk and pharmaceutical dosage forms via derivatization with dansyl chloride

A sensitive, simple and rapid spectrofluorimetric method has been developed for the determination of both Fenoterol hydrobromide (FNT) and Ritodrine hydrochloride (RTH) in pure and dosage forms. The method is based on derivatization using dansyl chloride (DNS-Cl) as fluorogenic agent and measuring the fluorescence of the products at emission wavelengths of 517 and 515 nm after excitation at 348 and 343 nm for FNT and RTH, respectively. Different experimental parameters affecting the fluorescence intensities were carefully studied and optimized. The relation between fluorescence intensities and drug concentrations were rectilinear over the concentration range of 0.25–6.0 μg/mL for both drugs with a minimum detectability of 0.065 and 0.045 μg/mL for FNT and RTH, respectively. The percentage recoveries ±SD were 100.1 ± 0.9, 99.9 ± 0.6 for FNT and RTH respectively. The proposed method was successfully applied to the determination of both drugs in their commercial dosage forms. The obtained results were statistically validated and agreed well with those obtained with reference methods. A suggestion for the reaction pathway with DNS-Cl was postulated.     

Spectrophotometric and spectrofluorimetric methods for the determination of ramipril in its pure and dosage form

This paper describes three sensitive spectrophotometric and spectrofluorimetric methods for determination of ramipril in its pure form and pharmaceutical tablets. The first method is based on the oxidation of the drug with 1-chlorobenzotriazole reagent (CBT) in strong alkaline medium followed by measuring the absorbance at 350 nm. The method obeys Beer's law over concentration range 15-50 microg ml(-1). For the second and third, both are non-extractive methods based on the formation of ternary complex between copper (II), eosin and ramipril in the presence of methylcellulose as surfactant. Spectrophotometrically, under the optimum condition, the ternary complex showed an absorption maximum at 543 nm. The method obeys Beer's law over concentration range of 20-80 microg ml(-1). A fluorescence quenching method for the determination of ramipril by forming this ternary complex was also investigated for the propose of enhance the sensitivity of the determination. The methods are simple, sensitive, and accurate. The results obtained are reproducible with a coefficient of variation less than 2%. The proposed have been successfully applied to the assay of ramipril in tablets. The results compare favorably with official method.     

Some spectrofluorimetric applications of the cerium(IV)-cerium(III) system

Cerium(III) ions in dilute sulphuric acid medium exhibit a characteristic fluorescence which has its excitation maximum at 260 nm and its fluorescence emission maximum at 350 nm. By utilising the osmium-catalysed redox reaction between cerium(IV) and arsenic(III), microgram amounts of arsenic (7.5–37.5 μg) may be determined by spectrofluorimetric measurement of the ceriurm(III) produced. The principle may be applied to the determination of several other ions which cannot yet be determined by direct spectrofluorimetry, e.g.. Fe(II) (5.6–28 μg), oxalate (8.8–44μg). Osmium(VIII) (0.05–0.2 μg) and iodide (0.6–2.5 μg) may be determined by their catalytic action.     

Spectrophotometric determination of cerium(IV) using a phenothiazine derivative.

A simple, rapid and sensitive spectrophotometric method has been proposed for the determination of cerium(IV) using a phenothiazine derivative, propionyl promazine phosphate (PPP). This method is based on the formation of a red-colored radical cation upon a reaction of PPP with cerium(IV) in a phosphoric acid medium having maximum absorbance at 513 nm. Beer's law is valid over the concentration range of 1-11 microg/ml with a Sandell's sensitivity value of 16.14 ng/cm2. The proposed method has been successfully applied to the analysis of magnesium-base cerium alloys and synthetic mixtures corresponding to various cerium alloys. Other phenothiazine derivatives viz. butaperazine dimaleate and propericiazine were also used for the determination of cerium(IV).     

Analysis of binary mixtures of flufenamic, meclofenamic and mefenamic acids by derivative synchronous fluorescence spectrometry

Second-derivative synchronous fluorescence spectrometry was used to develop a simple, rapid and sensitive spectrofluorimetric method for the determination of binary mixtures of the nonsteroidal antiinflammatory drugs flufenamic (FFA), meclofenamic (MCFA) and mefenamic (MFA) acids in serum and pharmaceutical formulations. The method is based on the intrinsic fluorescence of these compounds in chloroform. A Deltalambda=105 nm was used for the resolution of FFA-MFA and MFA-MCFA mixtures, whereas the FFA-MCFA mixture was determined at Deltalambda=40 nm. Serum samples are treated with trichloroacetic acid to remove the proteins, and the analytes are extracted in chloroform prior to determination. Pharmaceutical preparations were analysed without prior separation steps.     

Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD-Cl)

Two sensitive and selective spectrofluorimetric and spectrophotometric stability-indicating methods have been developed for the determination of some non-steroidal anti-inflammatory oxicam derivatives namely lornoxicam (Lx), tenoxicam (Tx) and meloxicam (Mx) after their complete alkaline hydrolysis. The methods are based on derivatization of alkaline hydrolytic products with 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD-Cl). The products showed an absorption maximum at 460 nm for the three studied drugs and fluorescence emission peak at 535 nm in methanol. The color was stable for at least 48 h. The optimum conditions of the reaction were investigated and it was found that the reaction proceeds quantitatively at pH 8, after heating in a boiling water bath for 30 min. The methods were found to be linear in the ranges of 1-10 microg ml(-1) for Lx and Tx and 0.5-4.0 microg ml(-1) for Mx for spectrophotometric method, while 0.05-1.0 microg ml(-1) for Lx and Tx and 0.025-0.4 microg ml(-1) for Mx for the spectrofluorimetric method. The validity of the methods was assessed according to USP guidelines. Statistical analysis of the results revealed high accuracy and good precision. The suggested procedures could be used for the determination of the above mentioned drugs in pure and dosage forms as well as in the presence of their degradation products.